semaglutide patent expiration Novo Nordisk expiry opens door to cheaper weight-loss drugs in India What is the patent landscape

A metagenome-wide association study of gut microbiota in type 2 diabetes

However, emerging evidence suggests that the effects of GLP-1RAs extend beyond metabolic regulation

SOURCE: European Association for the Study of Obesity, news release, May 11, 2025 Copyright 2025 HealthDay

GLP-1 receptor agonists influence metabolism through three primary pathways: appetite modulation, glucose-dependent insulin secretion, and slowed gastric emptying

Work with your healthcare provider to compile baseline labs (BMI, vital signs, comorbid diagnoses, HbA1c if diabetic) and any prior weight-loss attemptswritten documentation strengthens prior authorization requests and speeds approval timelines

Acknowledgments The authors gratefully acknowledge the critical reviews and insights of Sarah Armstrong MD, Nancie MacIver MD PhD, and Lisa Rasbach PhD CPNP